Global Human Insulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 100330
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Human Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Human Insulin market size is estimated to be worth US$ 57460 million in 2021 and is forecast to a readjusted size of USD 104760 million by 2028 with a CAGR of 9.0% during review period. Short Acting accounting for % of the Human Insulin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Insulin Analogs and Biosimilars segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Human Insulin include B. Braun, Becton, Dickinson, Biocon, Biodel, and ELI Lilly, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Human Insulin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Insulin Analogs and Biosimilars

Human Insulin Biologics

Market segment by Application can be divided into

Short Acting

Intermediate Acting

Long Acting

Pre-Mix Insulin

The key market players for global Human Insulin market are listed below:

B. Braun

Becton, Dickinson

Biocon

Biodel

ELI Lilly

Julphar

NOVO Nordisk

Sanofi

Wockhardt

Ypsomed

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Human Insulin product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Human Insulin, with price, sales, revenue and global market share of Human Insulin from 2019 to 2022.

Chapter 3, the Human Insulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Human Insulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Insulin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Human Insulin.

Chapter 13, 14, and 15, to describe Human Insulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Human Insulin Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Human Insulin Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Insulin Analogs and Biosimilars

1.2.3 Human Insulin Biologics

1.3 Market Analysis by Application

1.3.1 Overview: Global Human Insulin Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Short Acting

1.3.3 Intermediate Acting

1.3.4 Long Acting

1.3.5 Pre-Mix Insulin

1.4 Global Human Insulin Market Size & Forecast

1.4.1 Global Human Insulin Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Human Insulin Sales in Volume (2017-2028)

1.4.3 Global Human Insulin Price (2017-2028)

1.5 Global Human Insulin Production Capacity Analysis

1.5.1 Global Human Insulin Total Production Capacity (2017-2028)

1.5.2 Global Human Insulin Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Human Insulin Market Drivers

1.6.2 Human Insulin Market Restraints

1.6.3 Human Insulin Trends Analysis

2 Manufacturers Profiles

2 Manufacturers Profiles

2.1 B. Braun

2.1.1 B. Braun Details

2.1.2 B. Braun Major Business

2.1.3 B. Braun Human Insulin Product and Services

2.1.4 B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Becton, Dickinson

2.2.1 Becton, Dickinson Details

2.2.2 Becton, Dickinson Major Business

2.2.3 Becton, Dickinson Human Insulin Product and Services

2.2.4 Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Biocon

2.3.1 Biocon Details

2.3.2 Biocon Major Business

2.3.3 Biocon Human Insulin Product and Services

2.3.4 Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Biodel

2.4.1 Biodel Details

2.4.2 Biodel Major Business

2.4.3 Biodel Human Insulin Product and Services

2.4.4 Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 ELI Lilly

2.5.1 ELI Lilly Details

2.5.2 ELI Lilly Major Business

2.5.3 ELI Lilly Human Insulin Product and Services

2.5.4 ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Julphar

2.6.1 Julphar Details

2.6.2 Julphar Major Business

2.6.3 Julphar Human Insulin Product and Services

2.6.4 Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 NOVO Nordisk

2.7.1 NOVO Nordisk Details

2.7.2 NOVO Nordisk Major Business

2.7.3 NOVO Nordisk Human Insulin Product and Services

2.7.4 NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 Sanofi

2.8.1 Sanofi Details

2.8.2 Sanofi Major Business

2.8.3 Sanofi Human Insulin Product and Services

2.8.4 Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 Wockhardt

2.9.1 Wockhardt Details

2.9.2 Wockhardt Major Business

2.9.3 Wockhardt Human Insulin Product and Services

2.9.4 Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 Ypsomed

2.10.1 Ypsomed Details

2.10.2 Ypsomed Major Business

2.10.3 Ypsomed Human Insulin Product and Services

2.10.4 Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Human Insulin Breakdown Data by Manufacturer

3 Human Insulin Breakdown Data by Manufacturer

3.1 Global Human Insulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Human Insulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Human Insulin

3.4 Market Concentration Rate

3.4.1 Top 3 Human Insulin Manufacturer Market Share in 2021

3.4.2 Top 6 Human Insulin Manufacturer Market Share in 2021

3.5 Global Human Insulin Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Human Insulin Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4 Market Analysis by Region

4.1 Global Human Insulin Market Size by Region

4.1.1 Global Human Insulin Sales in Volume by Region (2017-2028)

4.1.2 Global Human Insulin Revenue by Region (2017-2028)

4.2 North America Human Insulin Revenue (2017-2028)

4.3 Europe Human Insulin Revenue (2017-2028)

4.4 Asia-Pacific Human Insulin Revenue (2017-2028)

4.5 South America Human Insulin Revenue (2017-2028)

4.6 Middle East and Africa Human Insulin Revenue (2017-2028)

5 Market Segment by Type

5 Market Segment by Type

5.1 Global Human Insulin Sales in Volume by Type (2017-2028)

5.2 Global Human Insulin Revenue by Type (2017-2028)

5.3 Global Human Insulin Price by Type (2017-2028)

6 Market Segment by Application

6 Market Segment by Application

6.1 Global Human Insulin Sales in Volume by Application (2017-2028)

6.2 Global Human Insulin Revenue by Application (2017-2028)

6.3 Global Human Insulin Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7 North America by Country, by Type, and by Application

7.1 North America Human Insulin Sales by Type (2017-2028)

7.2 North America Human Insulin Sales by Application (2017-2028)

7.3 North America Human Insulin Market Size by Country

7.3.1 North America Human Insulin Sales in Volume by Country (2017-2028)

7.3.2 North America Human Insulin Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8 Europe by Country, by Type, and by Application

8.1 Europe Human Insulin Sales by Type (2017-2028)

8.2 Europe Human Insulin Sales by Application (2017-2028)

8.3 Europe Human Insulin Market Size by Country

8.3.1 Europe Human Insulin Sales in Volume by Country (2017-2028)

8.3.2 Europe Human Insulin Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Human Insulin Sales by Type (2017-2028)

9.2 Asia-Pacific Human Insulin Sales by Application (2017-2028)

9.3 Asia-Pacific Human Insulin Market Size by Region

9.3.1 Asia-Pacific Human Insulin Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Human Insulin Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10 South America by Region, by Type, and by Application

10.1 South America Human Insulin Sales by Type (2017-2028)

10.2 South America Human Insulin Sales by Application (2017-2028)

10.3 South America Human Insulin Market Size by Country

10.3.1 South America Human Insulin Sales in Volume by Country (2017-2028)

10.3.2 South America Human Insulin Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Human Insulin Sales by Type (2017-2028)

11.2 Middle East & Africa Human Insulin Sales by Application (2017-2028)

11.3 Middle East & Africa Human Insulin Market Size by Country

11.3.1 Middle East & Africa Human Insulin Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Human Insulin Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12 Raw Material and Industry Chain

12.1 Raw Material of Human Insulin and Key Manufacturers

12.2 Manufacturing Costs Percentage of Human Insulin

12.3 Human Insulin Production Process

12.4 Human Insulin Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Human Insulin Typical Distributors

13.3 Human Insulin Typical Customers

14 Research Findings and Conclusion

14 Research Findings and Conclusion

15 Appendix

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Human Insulin Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Human Insulin Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. B. Braun Basic Information, Manufacturing Base and Competitors

Table 4. B. Braun Major Business

Table 5. B. Braun Human Insulin Product and Services

Table 6. B. Braun Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Becton, Dickinson Basic Information, Manufacturing Base and Competitors

Table 8. Becton, Dickinson Major Business

Table 9. Becton, Dickinson Human Insulin Product and Services

Table 10. Becton, Dickinson Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Biocon Basic Information, Manufacturing Base and Competitors

Table 12. Biocon Major Business

Table 13. Biocon Human Insulin Product and Services

Table 14. Biocon Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Biodel Basic Information, Manufacturing Base and Competitors

Table 16. Biodel Major Business

Table 17. Biodel Human Insulin Product and Services

Table 18. Biodel Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. ELI Lilly Basic Information, Manufacturing Base and Competitors

Table 20. ELI Lilly Major Business

Table 21. ELI Lilly Human Insulin Product and Services

Table 22. ELI Lilly Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Julphar Basic Information, Manufacturing Base and Competitors

Table 24. Julphar Major Business

Table 25. Julphar Human Insulin Product and Services

Table 26. Julphar Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. NOVO Nordisk Basic Information, Manufacturing Base and Competitors

Table 28. NOVO Nordisk Major Business

Table 29. NOVO Nordisk Human Insulin Product and Services

Table 30. NOVO Nordisk Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Sanofi Basic Information, Manufacturing Base and Competitors

Table 32. Sanofi Major Business

Table 33. Sanofi Human Insulin Product and Services

Table 34. Sanofi Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Wockhardt Basic Information, Manufacturing Base and Competitors

Table 36. Wockhardt Major Business

Table 37. Wockhardt Human Insulin Product and Services

Table 38. Wockhardt Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. Ypsomed Basic Information, Manufacturing Base and Competitors

Table 40. Ypsomed Major Business

Table 41. Ypsomed Human Insulin Product and Services

Table 42. Ypsomed Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. Global Human Insulin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)

Table 44. Global Human Insulin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 45. Market Position of Manufacturers in Human Insulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 46. Global Human Insulin Production Capacity by Company, (K Doses): 2020 VS 2021

Table 47. Head Office and Human Insulin Production Site of Key Manufacturer

Table 48. Human Insulin New Entrant and Capacity Expansion Plans

Table 49. Human Insulin Mergers & Acquisitions in the Past Five Years

Table 50. Global Human Insulin Sales by Region (2017-2022) & (K Doses)

Table 51. Global Human Insulin Sales by Region (2023-2028) & (K Doses)

Table 52. Global Human Insulin Revenue by Region (2017-2022) & (USD Million)

Table 53. Global Human Insulin Revenue by Region (2023-2028) & (USD Million)

Table 54. Global Human Insulin Sales by Type (2017-2022) & (K Doses)

Table 55. Global Human Insulin Sales by Type (2023-2028) & (K Doses)

Table 56. Global Human Insulin Revenue by Type (2017-2022) & (USD Million)

Table 57. Global Human Insulin Revenue by Type (2023-2028) & (USD Million)

Table 58. Global Human Insulin Price by Type (2017-2022) & (USD/Dose)

Table 59. Global Human Insulin Price by Type (2023-2028) & (USD/Dose)

Table 60. Global Human Insulin Sales by Application (2017-2022) & (K Doses)

Table 61. Global Human Insulin Sales by Application (2023-2028) & (K Doses)

Table 62. Global Human Insulin Revenue by Application (2017-2022) & (USD Million)

Table 63. Global Human Insulin Revenue by Application (2023-2028) & (USD Million)

Table 64. Global Human Insulin Price by Application (2017-2022) & (USD/Dose)

Table 65. Global Human Insulin Price by Application (2023-2028) & (USD/Dose)

Table 66. North America Human Insulin Sales by Country (2017-2022) & (K Doses)

Table 67. North America Human Insulin Sales by Country (2023-2028) & (K Doses)

Table 68. North America Human Insulin Revenue by Country (2017-2022) & (USD Million)

Table 69. North America Human Insulin Revenue by Country (2023-2028) & (USD Million)

Table 70. North America Human Insulin Sales by Type (2017-2022) & (K Doses)

Table 71. North America Human Insulin Sales by Type (2023-2028) & (K Doses)

Table 72. North America Human Insulin Sales by Application (2017-2022) & (K Doses)

Table 73. North America Human Insulin Sales by Application (2023-2028) & (K Doses)

Table 74. Europe Human Insulin Sales by Country (2017-2022) & (K Doses)

Table 75. Europe Human Insulin Sales by Country (2023-2028) & (K Doses)

Table 76. Europe Human Insulin Revenue by Country (2017-2022) & (USD Million)

Table 77. Europe Human Insulin Revenue by Country (2023-2028) & (USD Million)

Table 78. Europe Human Insulin Sales by Type (2017-2022) & (K Doses)

Table 79. Europe Human Insulin Sales by Type (2023-2028) & (K Doses)

Table 80. Europe Human Insulin Sales by Application (2017-2022) & (K Doses)

Table 81. Europe Human Insulin Sales by Application (2023-2028) & (K Doses)

Table 82. Asia-Pacific Human Insulin Sales by Region (2017-2022) & (K Doses)

Table 83. Asia-Pacific Human Insulin Sales by Region (2023-2028) & (K Doses)

Table 84. Asia-Pacific Human Insulin Revenue by Region (2017-2022) & (USD Million)

Table 85. Asia-Pacific Human Insulin Revenue by Region (2023-2028) & (USD Million)

Table 86. Asia-Pacific Human Insulin Sales by Type (2017-2022) & (K Doses)

Table 87. Asia-Pacific Human Insulin Sales by Type (2023-2028) & (K Doses)

Table 88. Asia-Pacific Human Insulin Sales by Application (2017-2022) & (K Doses)

Table 89. Asia-Pacific Human Insulin Sales by Application (2023-2028) & (K Doses)

Table 90. South America Human Insulin Sales by Country (2017-2022) & (K Doses)

Table 91. South America Human Insulin Sales by Country (2023-2028) & (K Doses)

Table 92. South America Human Insulin Revenue by Country (2017-2022) & (USD Million)

Table 93. South America Human Insulin Revenue by Country (2023-2028) & (USD Million)

Table 94. South America Human Insulin Sales by Type (2017-2022) & (K Doses)

Table 95. South America Human Insulin Sales by Type (2023-2028) & (K Doses)

Table 96. South America Human Insulin Sales by Application (2017-2022) & (K Doses)

Table 97. South America Human Insulin Sales by Application (2023-2028) & (K Doses)

Table 98. Middle East & Africa Human Insulin Sales by Region (2017-2022) & (K Doses)

Table 99. Middle East & Africa Human Insulin Sales by Region (2023-2028) & (K Doses)

Table 100. Middle East & Africa Human Insulin Revenue by Region (2017-2022) & (USD Million)

Table 101. Middle East & Africa Human Insulin Revenue by Region (2023-2028) & (USD Million)

Table 102. Middle East & Africa Human Insulin Sales by Type (2017-2022) & (K Doses)

Table 103. Middle East & Africa Human Insulin Sales by Type (2023-2028) & (K Doses)

Table 104. Middle East & Africa Human Insulin Sales by Application (2017-2022) & (K Doses)

Table 105. Middle East & Africa Human Insulin Sales by Application (2023-2028) & (K Doses)

Table 106. Human Insulin Raw Material

Table 107. Key Manufacturers of Human Insulin Raw Materials

Table 108. Direct Channel Pros & Cons

Table 109. Indirect Channel Pros & Cons

Table 110. Human Insulin Typical Distributors

Table 111. Human Insulin Typical Customers

List of Figures

Figure 1. Human Insulin Picture

Figure 2. Global Human Insulin Revenue Market Share by Type in 2021

Figure 3. Insulin Analogs and Biosimilars

Figure 4. Human Insulin Biologics

Figure 5. Global Human Insulin Revenue Market Share by Application in 2021

Figure 6. Short Acting

Figure 7. Intermediate Acting

Figure 8. Long Acting

Figure 9. Pre-Mix Insulin

Figure 10. Global Human Insulin Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028

Figure 11. Global Human Insulin Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Human Insulin Sales (2017-2028) & (K Doses)

Figure 13. Global Human Insulin Price (2017-2028) & (USD/Dose)

Figure 14. Global Human Insulin Production Capacity (2017-2028) & (K Doses)

Figure 15. Global Human Insulin Production Capacity by Geographic Region: 2022 VS 2028

Figure 16. Human Insulin Market Drivers

Figure 17. Human Insulin Market Restraints

Figure 18. Human Insulin Market Trends

Figure 19. Global Human Insulin Sales Market Share by Manufacturer in 2021

Figure 20. Global Human Insulin Revenue Market Share by Manufacturer in 2021

Figure 21. Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 22. Top 3 Human Insulin Manufacturer (Revenue) Market Share in 2021

Figure 23. Top 6 Human Insulin Manufacturer (Revenue) Market Share in 2021

Figure 24. Global Human Insulin Sales Market Share by Region (2017-2028)

Figure 25. Global Human Insulin Revenue Market Share by Region (2017-2028)

Figure 26. North America Human Insulin Revenue (2017-2028) & (USD Million)

Figure 27. Europe Human Insulin Revenue (2017-2028) & (USD Million)

Figure 28. Asia-Pacific Human Insulin Revenue (2017-2028) & (USD Million)

Figure 29. South America Human Insulin Revenue (2017-2028) & (USD Million)

Figure 30. Middle East & Africa Human Insulin Revenue (2017-2028) & (USD Million)

Figure 31. Global Human Insulin Sales Market Share by Type (2017-2028)

Figure 32. Global Human Insulin Revenue Market Share by Type (2017-2028)

Figure 33. Global Human Insulin Price by Type (2017-2028) & (USD/Dose)

Figure 34. Global Human Insulin Sales Market Share by Application (2017-2028)

Figure 35. Global Human Insulin Revenue Market Share by Application (2017-2028)

Figure 36. Global Human Insulin Price by Application (2017-2028) & (USD/Dose)

Figure 37. North America Human Insulin Sales Market Share by Type (2017-2028)

Figure 38. North America Human Insulin Sales Market Share by Application (2017-2028)

Figure 39. North America Human Insulin Sales Market Share by Country (2017-2028)

Figure 40. North America Human Insulin Revenue Market Share by Country (2017-2028)

Figure 41. United States Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Canada Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Mexico Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Europe Human Insulin Sales Market Share by Type (2017-2028)

Figure 45. Europe Human Insulin Sales Market Share by Application (2017-2028)

Figure 46. Europe Human Insulin Sales Market Share by Country (2017-2028)

Figure 47. Europe Human Insulin Revenue Market Share by Country (2017-2028)

Figure 48. Germany Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. France Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. United Kingdom Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Russia Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Italy Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Asia-Pacific Human Insulin Sales Market Share by Region (2017-2028)

Figure 54. Asia-Pacific Human Insulin Sales Market Share by Application (2017-2028)

Figure 55. Asia-Pacific Human Insulin Sales Market Share by Region (2017-2028)

Figure 56. Asia-Pacific Human Insulin Revenue Market Share by Region (2017-2028)

Figure 57. China Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Korea Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America Human Insulin Sales Market Share by Type (2017-2028)

Figure 64. South America Human Insulin Sales Market Share by Application (2017-2028)

Figure 65. South America Human Insulin Sales Market Share by Country (2017-2028)

Figure 66. South America Human Insulin Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East & Africa Human Insulin Sales Market Share by Type (2017-2028)

Figure 70. Middle East & Africa Human Insulin Sales Market Share by Application (2017-2028)

Figure 71. Middle East & Africa Human Insulin Sales Market Share by Region (2017-2028)

Figure 72. Middle East & Africa Human Insulin Revenue Market Share by Region (2017-2028)

Figure 73. Turkey Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Egypt Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South Africa Human Insulin Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Manufacturing Cost Structure Analysis of Human Insulin in 2021

Figure 78. Manufacturing Process Analysis of Human Insulin

Figure 79. Human Insulin Industrial Chain

Figure 80. Sales Channel: Direct Channel vs Indirect Channel

Figure 81. Methodology

Figure 82. Research Process and Data Source